The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine
Open accessAbstract
Methylphenidate (MP) (ritalin) is widely used in the treatment of children and adolescents with attention deficit hyperactivity disorder, but little is known about therapeutic mechanisms or about possible consequences of long-term exposure. To more closely simulate the clinical use of the drug, we orally administered MP to adolescent rats during the dark-active phase of the circadian cycle at doses (0.75-3.0 mg/kg) below threshold for locomotor activation. We found that doses in this range increased extracellular norepinephrine in hippocampus without affecting dopamine in nucleus accumbens. These results suggest that norepinephrine systems may play an important role in the therapeutic action of this drug. To examine one potential consequence of long-term exposure to MP, i.e., the development of locomotor sensitization, an adaptational change that has been implicated in drug abuse liability, animals received three daily oral administrations of these doses of MP for up to 4 weeks through adolescence. The animals were then challenged with methamphetamine (0.5 mg/kg). We found that the behavioral response to MP did not change during the course of chronic treatment and that MP-pretreated animals did not exhibit a sensitized locomotor response to the methamphetamine challenge. We propose that, to the extent that this treatment protocol more closely reflects clinical exposure patterns, the relative insensitivity of accumbens dopamine to the acute administration of these MP doses, and the corresponding absence of evidence for the development of locomotor sensitization, supports one clinical view that there is little abuse liability associated with low dose, long-term MP treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lower doses in rats improve PFC attention and working memory function, enhance PFC neuronal response, and reduce locomotor hyperactivity in juveniles (Arnsten and Dudley, 2005; Berridge et al., 2006; Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Kuczenski and Segal, 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When administered in appropriate doses, these medications improve PFC function both in healthy human subjects (Elliott et al., 1997) and in animals (Arnsten and Dudley, 2005), including the reduction of locomotor hyperactivity in juvenile rats (Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Kuczenski and Segal, 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,108
Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,360
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
D1 receptors in prefrontal cells and circuits
Goldman-Rakic, P. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00045-4 · Cited by 822
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Research works printed but not linked: 3
- Sagvolden T (2001) The spontaneously hypertensive rat as a model for ADHD. In: Stimulant drugs and ADHD: basic and clinical neuro- science (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 221-237. New York: Oxford UP.
- Solanto MV, Arnsten AFT, Castellanos FX (2001) The neuroscience of stimulant drugs in ADHD. In: Stimulant drugs and ADHD: basic and clinical neuroscience (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 355-379. New York: Oxford UP.
- Taylor JR, Jentsch JD (2001) Stimulant effects on striatal and cortical dopamine systems involved in reward-related behavior and impulsivity: implications for ADHD. In: Stimulant drugs and ADHD: basic and clinical neuroscience (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 104 -133. New York: Oxford UP.
Cited by
Sorted by citations
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
Neurobiology of Executive Functions: Catecholamine Influences on Prefrontal Cortical Functions
Arnsten, A. F. T., & Li, B.-M. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.019 · Cited by 948
Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617
Stimulants: Therapeutic Actions in ADHD
Arnsten, A. F. T. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301164 · Cited by 473
Arnsten, A. F. T., & Pliszka, S. R. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.01.020 · Cited by 383
Arnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
Robinson, E. S. J., Eagle, D. M., Mar, A. C., Bari, A., Banerjee, G., Jiang, X., Dalley, J. W., & Robbins, T. W. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301487 · Cited by 359
Arnsten, A. F. T., Scahill, L. D., & Findling, R. L. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0098 · Cited by 314
Windows of vulnerability to psychopathology and therapeutic strategy in the adolescent rodent model
Adriani, W., & Laviola, G. (2004) · Behavioural Pharmacology · doi:10.1097/00008877-200409000-00005 · Cited by 267
Brennan, A. R., & Arnsten, A. F. T. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1417.007 · Cited by 267
Potential adverse effects of amphetamine treatment on brain and behavior: a review
Berman, S. M., Kuczenski, R. T., McCracken, J. T., & London, E. D. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.90 · Cited by 263
Self-citationNutt, D. J., Fone, K., Asherson, P., Bramble, D., Hill, P., Matthews, K., Morris, K. A., Santosh, P., Sonuga-Barke, E., Taylor, E., et al. (2007) · Journal of Psychopharmacology · doi:10.1177/0269881106073219 · Cited by 259
Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. G. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007054 · Cited by 259
Enduring behavioral effects of early exposure to methylphenidate in rats
Carlezon, W. A., Mague, S. D., & Andersen, S. L. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.020 · Cited by 248
Gamo, N. J., Wang, M., & Arnsten, A. F. T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.015 · Cited by 232
Koda, K., Ago, Y., Cong, Y., Kita, Y., Takuma, K., & Matsuda, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06750.x · Cited by 222
ADHD and the Prefrontal Cortex
Arnsten, A. F. T. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.018 · Cited by 220
Stimulus-dependent dopamine release in attention-deficit/hyperactivity disorder.
Sikström, S., & Söderlund, G. (2007) · Psychological Review · doi:10.1037/0033-295x.114.4.1047 · Cited by 205
Arnsten, A. F. T. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhm033 · Cited by 200
Spencer, T. J., Biederman, J., Madras, B. K., Faraone, S. V., Dougherty, D. D., Bonab, A. A., & Fischman, A. J. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.036 · Cited by 185
Emergence of sex differences in the development of substance use and abuse during adolescence
Kuhn, C. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.06.003 · Cited by 192
Stimulants and the developing brain
Andersen, S. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.009 · Cited by 168
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164
Berridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160
Wang, G.-J., Volkow, N. D., Wigal, T., Kollins, S. H., Newcorn, J. H., Telang, F., Logan, J., Jayne, M., Wong, C. T., Han, H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063023 · Cited by 144
Dopaminergic and Noradrenergic Contributions to Functionality in ADHD: The Role of Methylphenidate
Engert, V., & Pruessner, J. (2008) · Current Neuropharmacology · doi:10.2174/157015908787386069 · Cited by 146
Andersen, S. L., & Navalta, C. P. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.06.002 · Cited by 141
Dafny, N., & Yang, P. B. (2005) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2005.10.005 · Cited by 139
Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses
Genro, J. P., Kieling, C., Rohde, L. A., & Hutz, M. H. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.17 · Cited by 139
Zhu, J., Zhang, X., Xu, Y., Spencer, T. J., Biederman, J., & Bhide, P. G. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.1041-12.2012 · Cited by 125
Faraone, S. V., Spencer, T. J., Madras, B. K., Zhang‐James, Y., & Biederman, J. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.126 · Cited by 131
Kuczenski, R. T., & Segal, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.036 · Cited by 121
Self-citationMethylphenidate and its Isomers
Heal, D. J., & Pierce, D. M. (2006) · CNS Drugs · doi:10.2165/00023210-200620090-00002 · Cited by 119
Devilbiss, D. M., & Berridge, C. W. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.04.037 · Cited by 118
Beane, M., & Marrocco, R. T. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.001 · Cited by 119
Gray, J. D., Punsoni, M., Tabori, N. E., Melton, J. T., Fanslow, V., Ward, M. J., Zupan, B., Menzer, D., Rice, J., Drake, C. T., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0109-07.2007 · Cited by 113
Berridge, C. W., & Spencer, R. C. (2016) · Brain Research · doi:10.1016/j.brainres.2015.11.024 · Cited by 112
Carlezon, W. A., & Konradi, C. L. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.06.021 · Cited by 108
What are the long-term effects of methylphenidate treatment?
Volkow, N. D., & Insel, T. R. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.10.019 · Cited by 111
Stimulants: use and abuse in the treatment of attention deficit hyperactivity disorder
Fone, K. C. F., & Nutt, D. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.10.001 · Cited by 110
Bari, A., & Robbins, T. W. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3141-6 · Cited by 105
Methylphenidate treatment induces oxidative stress in young rat brain
Martins, M. R., Reinke, A., Petronilho, F. C., Gomes, K. M., Dal-Pizzol, F., & Quevedo, J. (2006) · Brain Research · doi:10.1016/j.brainres.2006.01.004 · Cited by 105
Methylphenidate Disrupts Social Play Behavior in Adolescent Rats
Vanderschuren, L. J. M. J., Trezza, V., Griffioen-Roose, S., Schiepers, O. J. G., Van Leeuwen, N., De Vries, T. J., & Schoffelmeer, A. N. M. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.10 · Cited by 105
Psychostimulants and motivated behavior: Arousal and cognition
Berridge, C. W., & Arnsten, A. F. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.11.005 · Cited by 104
Thanos, P. K., Michaelides, M., Benveniste, H., Wang, G. J., & Volkow, N. D. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2007.05.020 · Cited by 100
Klein, M., Onnink, A. M. H., van Eijk, K. R., Wolfers, T., Harich, B., Shi, Y., Dammers, J. T., Vásquez, A. A., Hoogman, M., & Franke, B. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.01.013 · Cited by 116
Association of Norepinephrine Transporter Gene With Methylphenidate Response
Yang, L., Wang, Y., Li, J., & Faraone, S. V. (2004) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000131134.63368.46 · Cited by 97
Advancing the spontaneous hypertensive rat model of attention deficit/hyperactivity disorder.
Kantak, K. M., Singh, T., Kerstetter, K. A., Dembro, K. A., Mutebi, M. M., Harvey, R. C., Deschepper, C. F., & Dwoskin, L. P. (2008) · Behavioral Neuroscience · doi:10.1037/0735-7044.122.2.340 · Cited by 95
Hall, D. A., Stanis, J. J., Avila, H. M., & Gulley, J. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0923-8 · Cited by 99
Berridge, C. W., Shumsky, J. S., Andrzejewski, M. E., McGaughy, J. A., Spencer, R. C., Devilbiss, D. M., & Waterhouse, B. D. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.07.022 · Cited by 94
An, L., Cao, X.-H., Cao, Q.-J., Sun, L., Yang, L., Zou, Q.-H., Katya, R., Zang, Y.-F., & Wang, Y.-F. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.27 · Cited by 88
Oberlin, B. G., Alford, J. L., & Marrocco, R. T. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.06.041 · Cited by 92
Bari, A., & Aston-Jones, G. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.07.020 · Cited by 85
Achat‐Mendes, C. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00135-7 · Cited by 87
Harvey, R. C., Sen, S., Deaciuc, A., Dwoskin, L. P., & Kantak, K. M. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.223 · Cited by 86
Berridge, C. W., & Stalnaker, T. A. (2002) · Synapse · doi:10.1002/syn.10131 · Cited by 86
Sun, H., Cocker, P. J., Zeeb, F. D., & Winstanley, C. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2419-9 · Cited by 87
Mague, S. D., Andersen, S. L., & Carlezon, W. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.10.037 · Cited by 84
Tamminga, H. G. H., Reneman, L., Huizenga, H. M., & Geurts, H. M. (2016) · Psychological Medicine · doi:10.1017/s0033291716000350 · Cited by 82
Juvenile Administration of Methylphenidate Attenuates Adult Hippocampal Neurogenesis
Lagace, D. C., Yee, J. K., Bolaños, C. A., & Eisch, A. J. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.009 · Cited by 79
METHYLPHENIDATE (RITALIN): BEHAVIORAL STUDIES IN THE RAT
Askenasy, E. P., Taber, K. H., Yang, P. B., & Dafny, N. (2007) · International Journal of Neuroscience · doi:10.1080/00207450600910176 · Cited by 78
Influence of methylphenidate on brain development – an update of recent animal experiments
Grund, T., Lehmann, K., Bock, N., Rothenberger, A., & Teuchert, G. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-2 · Cited by 77
Scherer, E. B. S., da Cunha, M. J., Matté, C., Schmitz, F., Netto, C. A., & Wyse, Â. T. D. S. (2010) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2010.06.002 · Cited by 79
Methylphenidate Exerts Dose-Dependent Effects on Glutamate Receptors and Behaviors
Cheng, J., Zhe, X., Duffney, L. J., Wei, J., Liu, A., Liu, S., Chen, G., & Yan, Z. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.04.003 · Cited by 77
Psychostimulants Act Within the Prefrontal Cortex to Improve Cognitive Function
Spencer, R. C., Klein, R. M., & Berridge, C. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.12.002 · Cited by 74
Carboni, E., Silvagni, A., Valentini, V., & Chiara, G. D. (2003) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2003.08.008 · Cited by 70
Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge
Devilbiss, D. M., & Berridge, C. W. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110015 · Cited by 67
Chronic pretreatment with methylphenidate induces cross-sensitization with amphetamine
Yang, P. B., Swann, A. C., & Dafny, N. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00673-8 · Cited by 65
Effects of Methylphenidate on Weight Gain and Food Intake in Hypothalamic Obesity
Elfers, C., & Roth, C. L. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00078 · Cited by 66
Fleming, S. M., Delville, Y., & Schallert, T. J. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.05.024 · Cited by 65
de Farias, A. C., Cunha, A., Benko, C. R., McCracken, J. T., da Costa, M. T. Z., Farias, L. G., & Cordeiro, M. L. (2010) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0073 · Cited by 64
An Overview of the Association between Schizotypy and Dopamine
Mohr, C., & Ettinger, U. (2014) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2014.00184 · Cited by 63
Balcioglu, A., Ren, J.-Q., McCarthy, D., Spencer, T. J., Biederman, J., & Bhide, P. G. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.025 · Cited by 60
Fagundes, A. O., Rezin, G. T., Zanette, F., Grandi, E., Assis, L. C., Dal‐Pizzol, F., Quevedo, J., & STRECK, E. L. (2006) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2006.11.001 · Cited by 59
Hand, D. J., Fox, A. T., & Reilly, M. P. (2009) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3283305ee1 · Cited by 59
Chronic administration of methylphenidate produces neurophysiological and behavioral sensitization
Yang, P. B., Swann, A. C., & Dafny, N. (2007) · Brain Research · doi:10.1016/j.brainres.2007.01.108 · Cited by 59
Caprioli, D., Jupp, B., Hong, Y. T., Sawiak, S. J., Ferrari, V., Wharton, L., Williamson, D. J., McNabb, C. B., Berry, D. W., Aigbirhio, F. I., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3890-14.2015 · Cited by 59
Specificity and impact of adrenergic projections to the midbrain dopamine system
Mejías-Aponte, C. A. (2016) · Brain Research · doi:10.1016/j.brainres.2016.01.036 · Cited by 58
Komater, V. A., Browman, K. E., Curzon, P., Hancock, A. A., Decker, M. W., & Fox, G. B. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1431-0 · Cited by 59
Pascoli, V., Valjent, E., Corbillé, A.-G., Corvol, J.-C., Tassin, J.-P., Girault, J.-A., & Hervé, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011809 · Cited by 59
Juvenile methylphenidate reduces prefrontal cortex plasticity via D3 receptor and BDNF in adulthood
Andersen, S. L., & Sonntag, K. (2014) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2014.00001 · Cited by 57
Ferguson, S. A., Paule, M. G., Cada, A. M., Fogle, C. M., Gray, E. P., & Berry, K. J. (2007) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2007.07.001 · Cited by 58
Distinct Age-Dependent Effects of Methylphenidate on Developing and Adult Prefrontal Neurons
Urban, K. R., Waterhouse, B. D., & Gao, W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.04.018 · Cited by 57
Atomoxetine facilitates attentional set shifting in adolescent rats
Cain, R. E., Wasserman, M. C., Waterhouse, B. D., & McGaughy, J. A. (2011) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2011.04.003 · Cited by 55
Methylphenidate-induced impulsivity: pharmacological antagonism by β-adrenoreceptor blockade
Milstein, J. A., Dalley, J. W., & Robbins, T. W. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108098146 · Cited by 56
Acetyl-l-carnitine reduces impulsive behaviour in adolescent rats
Adriani, W., Rea, M., Baviera, M., Invernizzi, R. W., Carli, M., Ghirardi, O., Caprioli, A., & Laviola, G. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1892-9 · Cited by 58
Borycz, J., Zapata, A. G., Quiroz, C., Volkow, N. D., & Ferré, S. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301445 · Cited by 53
Jenson, D., Yang, K., Acevedo-Rodriguez, A., Levine, A., Broussard, J. I., Tang, J., & Dani, J. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.10.029 · Cited by 52
Algahim, M. F., Yang, P. B., Wilcox, V. T., Burau, K. D., Swann, A. C., & Dafny, N. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.10.021 · Cited by 52
A pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
Thanos, P. K., Robison, L. S., Steier, J., Hwang, Y. F., Cooper, T. B., Swanson, J. M., Komatsu, D. E., Hadjiargyrou, M., & Volkow, N. D. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.01.005 · Cited by 51
Yang, P. B., Swann, A. C., & Dafny, N. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.014 · Cited by 51
Yang, P. B., Swann, A. C., & Dafny, N. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-3 · Cited by 51
Chase, T. D., CARREY, N. J., Soo, E. C., & Wilkinson, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.10.035 · Cited by 51
Urban, K. R., Li, Y., & Gao, W. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.01.004 · Cited by 51
Williard, R. L., Middaugh, L. D., Zhu, H., & Patrick, K. S. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e3280143226 · Cited by 49
Schmitz, F., Scherer, E. B. S., Machado, F. R., da Cunha, A. A., Tagliari, B., Netto, C. A., & Wyse, Â. T. D. S. (2012) · Metabolic Brain Disease · doi:10.1007/s11011-012-9335-5 · Cited by 47
LeBlanc-Duchin, D., & Taukulis, H. K. (2007) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2007.04.010 · Cited by 47
Methylphenidate amplifies long-term plasticity in the hippocampus via noradrenergic mechanismsPreprint
Dommett, E. J., Henderson, E. L., Westwell, M. S., & Greenfield, S. A. (2008) · Learning & Memory · doi:10.1101/lm.1092608 · Cited by 48
Valvassori, S. S., Frey, B. N., Martins, M. R., Réus, G. Z., Schimidtz, F., Inácio, C. G., Kapczinski, F. P., & Quevedo, J. (2007) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e328153daf5 · Cited by 47
Lepelletier, F.-X., Tauber, C., Nicolas, C., Solinas, M., Castelnau, P., Belzung, C., Emond, P., Cortese, S., Faraone, S. V., Chalon, S., et al. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu044 · Cited by 48
Metadata
- Authors
- Kuczenski, R., & Segal, D. S.
- Affiliations
- University of California San Diego (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 7264-7271
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757883
- OpenAlex
- W2159875740
- Cited by
- 316
- References
- 75
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 12 · 2017: 12 · 2016: 10 · 2015: 28 · 2014: 16 · 2013: 21 · 2012: 21
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- University of California, San Diego
- National Institute on Drug Abuse (R01DA001568)
- NIH Clinical Center
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- methylphenidate, adolescent rats, hippocampus, nucleus accumbens dopamine, locomotor sensitization, cross-sensitization, abuse liability, attention deficit hyperactivity disorder, long-term drug exposure
- MeSH terms
- Administration, Oral, Age Factors, Animals, Behavior, Animal, Dopamine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Extracellular Space, Hippocampus, Male, Methamphetamine, Methylphenidate, Motor Activity, Norepinephrine, Nucleus Accumbens, Time, Rats, Sprague-Dawley, Microdialysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review